| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.2B | $11.7B | $10.4B | $9.6B | $6.2B | $3.6B | $8.8B | $8.3B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.3B | $0.6B | $0.4B | $0.1B | $0.7B | $-1.8B | $1.1B | $0.6B |
| Net Income | $0.1B | $0.4B | $0.2B | $0.1B | $0.5B | $-1.3B | $0.8B | $0.4B |
| EPS (Basic) | $0.85 | $3.13 | $1.84 | $0.46 | $3.82 | $-10.72 | $6.24 | $3.55 |
| EPS (Diluted) | $0.83 | $3.08 | $1.83 | $0.45 | $3.77 | $-10.72 | $6.19 | $3.52 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $20.4B | $19.8B | $14.6B | $14.2B | $14.0B | $14.0B | $13.0B | $10.9B |
| Current Assets | $3.3B | $3.8B | $2.7B | $3.0B | $3.9B | $4.0B | $2.0B | $1.8B |
| Cash & Equivalents | $0.6B | $1.2B | $0.3B | $0.3B | $0.5B | $1.4B | $0.2B | $0.1B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $6.6B | $6.1B | $4.5B | $4.5B | $4.0B | $4.3B | $3.2B | $2.9B |
| Stockholders' Equity | $4.1B | $4.4B | $4.1B | $3.8B | $3.8B | $3.0B | $4.3B | $3.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.2B | $1.5B | $1.1B | $1.4B | $1.0B | $-0.2B | $1.7B | $1.2B |
| Investing Cash Flow | $-1.6B | $-0.6B | $-1.0B | $-1.2B | $-1.0B | $-0.6B | $-0.8B | $-0.6B |
| Capital Expenditures | — | — | $1.5B | $1.7B | $0.3B | $0.2B | $0.7B | $1.0B |
| Financing Cash Flow | $-0.2B | $0.1B | $-0.1B | $-0.3B | $-0.9B | $2.0B | $-0.8B | $-0.6B |